| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROOT JONATHAN D | Director | C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD | /s/ Leonard Greenstein, as attorney-in-fact for Jonathan Root | 22 Jul 2025 | 0001225480 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CARL | Series A Preferred Stock | 22 Jul 2025 | Common Stock | 2.95M | See Footnotes | F1, F4, F5 | |||||||
| holding | CARL | Series B Preferred Stock | 22 Jul 2025 | Common Stock | 825K | See Footnotes | F1, F4, F5 | |||||||
| holding | CARL | Series C Preferred Stock | 22 Jul 2025 | Common Stock | 532K | See Footnotes | F1, F4, F5 | |||||||
| holding | CARL | Series A Preferred Stock | 22 Jul 2025 | Common Stock | 150K | See Footnotes | F2, F4, F5 | |||||||
| holding | CARL | Series B Preferred Stock | 22 Jul 2025 | Common Stock | 41.9K | See Footnotes | F2, F4, F5 | |||||||
| holding | CARL | Series C Preferred Stock | 22 Jul 2025 | Common Stock | 27K | See Footnotes | F2, F4, F5 | |||||||
| holding | CARL | Series C Preferred Stock | 22 Jul 2025 | Common Stock | 1.12M | See Footnotes | F3, F4, F5 |
| Id | Content |
|---|---|
| F1 | Stock held by U.S. Venture Partners XII, L.P. ("USVP XII"). |
| F2 | Stock held by U.S. Venture Partners XII-A, L.P. ("USVP XII-A"). |
| F3 | Stock held by U.S. Venture Partners Select Fund I, L.P. ("USVP SFI"), on its own behalf and as nominee for U.S. Venture Partners Select Fund I-A, L.P. ("USVP SFI-A"). |
| F4 | Presidio Management Group XII, L.L.C ("PMG XII") is the general partner of USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C ("PMG SFI," and, together with USVP XII, USVP XII-A, USVP SFI, USVP SFI-A, and PMG XII, "USVP") is the general partner of USVP SFI and USVP SFI-A. The Reporting Person is a managing member of PMG XII and PMG SFI and may be deemed to share voting and dispositive power over the stock held by USVP. The Reporting Person disclaims beneficial ownership of such stock, except to the extent of any pecuniary interest therein. |
| F5 | These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the "Reverse Split"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis and have no expiration date. |